Prot #LP0162-1337: Long-term extension trial in subjects with atopic dermatitis who participated in previous tralokinumab trials – ECZTEND

Project: Research project

Project Details

StatusActive
Effective start/end date3/1/193/1/22

Funding

  • LEO Pharma Inc. (Prot #LP0162-1337)